Diffuse Optical Tomography Imaging of Chemotherapy-Induced Changes in Breast Tissue Metabolism
Breast cancer is fast becoming the leading cause of mortality in women worldwide. As of this year, there are more than 3.1 million women with a history of breast cancer in the U.S., and about 41,760 women are expected to die from this disease. Neoadjuvant chemotherapy (NAC) has become a well-establi...
Main Author: | Altoé, Mirella Lorrainy |
---|---|
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://doi.org/10.7916/d8-69vw-sa90 |
Similar Items
-
Neoadjuvant Chemotherapy Monitoring of Breast Cancer Patients with Diffuse Optical Tomographic Imaging
by: Gunther, Jacqueline E.
Published: (2016) -
Early Therapeutic Prediction Based on Tumor Hemodynamic Response Imaging: Clinical Studies in Breast Cancer with Time-Resolved Diffuse Optical Spectroscopy
by: Shigeto Ueda, et al.
Published: (2018-12-01) -
Study of executive function in women with breast cancer undergoing chemotherapy
by: O. Amani, et al.
Published: (2017-01-01) -
Incidence of chemotherapy-induced amenorrhea in non-menopausal women with breast cancer
by: Shahrbanoo Keihanian, et al.
Published: (2009-01-01) -
Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy
by: Sales ACV, et al.
Published: (2020-10-01)